Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
December 29 2021 - 5:08AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer Pursuant to Rule
13a-16 or 15d-16
Under the Securities Exchange Act of 1934
For the Month of December, 2021
Commission File Number: 001-37353
BIONDVAX PHARMACEUTICALS LTD.
(Translation of registrant’s name into English)
Jerusalem BioPark, 2nd Floor
Hadassah Ein Kerem Campus
Jeusalem, Israel
(Address of principal executive office)
Indicate by check mark whether the registrant files
or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒
Form 40-F ☐
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Attached
and incorporated by reference herein are the following exhibits related to the Company's contemplated underwritten public offering of
4,144,068 American Depositary Shares (“ADSs”), each representing forty ordinary shares, including ADSs issuable upon exercise
in full of the underwriters’ over-allotment option.
Exhibit Index
This report
on Form 6-K shall be incorporated by reference into any Registration Statement filed by the Registrant that by its terms automatically
incorporates the Company’s filings and submissions with the SEC under Sections 13(a), 13(c) or 15(d) of the Securities Exchange
Act of 1934.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
BiondVax Pharmaceuticals Ltd.
|
|
|
|
Date: December 29, 2021
|
By:
|
/s/ Amir Reichman
|
|
|
Amir Reichman
|
|
|
Chief Executive Officer
|
2
Biovaxys Technology (PK) (USOTC:BVAXF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Biovaxys Technology (PK) (USOTC:BVAXF)
Historical Stock Chart
From Jul 2023 to Jul 2024